| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |